These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 22633984)
41. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters. Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783 [TBL] [Abstract][Full Text] [Related]
42. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Li XM; Perry KW; Wong DT Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599 [TBL] [Abstract][Full Text] [Related]
43. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Belcher AM; O'Dell SJ; Marshall JF Neuropsychopharmacology; 2005 Nov; 30(11):2026-34. PubMed ID: 15900317 [TBL] [Abstract][Full Text] [Related]
44. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress. Novick AM; Forster GL; Hassell JE; Davies DR; Scholl JL; Renner KJ; Watt MJ Neuropharmacology; 2015 Oct; 97():194-200. PubMed ID: 26056032 [TBL] [Abstract][Full Text] [Related]
45. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Yeh TL; Chen KC; Lin SH; Lee IH; Chen PS; Yao WJ; Lee SY; Yang YK; Lu RB; Liao MH; Chiu NT Psychopharmacology (Berl); 2012 Mar; 220(1):55-64. PubMed ID: 21881874 [TBL] [Abstract][Full Text] [Related]
46. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats. Quinton MS; Yamamoto BK Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543 [TBL] [Abstract][Full Text] [Related]
47. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612 [TBL] [Abstract][Full Text] [Related]
49. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors. Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503 [TBL] [Abstract][Full Text] [Related]
50. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662 [TBL] [Abstract][Full Text] [Related]
52. [Effects of methamphetamine on responsiveness to conditioned fear stress]. Tsuchiya K Hokkaido Igaku Zasshi; 1999 Jan; 74(1):41-52. PubMed ID: 10331059 [TBL] [Abstract][Full Text] [Related]
53. Role of serotonin transporter function in rat orbitofrontal cortex in impulsive choice. Darna M; Chow JJ; Yates JR; Charnigo RJ; Beckmann JS; Bardo MT; Dwoskin LP Behav Brain Res; 2015 Oct; 293():134-42. PubMed ID: 26183652 [TBL] [Abstract][Full Text] [Related]
54. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats. Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372 [TBL] [Abstract][Full Text] [Related]
55. Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters. Fleckenstein AE; Beyeler ML; Jackson JC; Wilkins DG; Gibb JW; Hanson GR Eur J Pharmacol; 1997 Apr; 324(2-3):179-86. PubMed ID: 9145769 [TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo. Schreiber R; Campbell U; Quinton MS; Hardy LW; Fang QK; Lew R Biomed Pharmacother; 2022 Sep; 153():113359. PubMed ID: 35785702 [TBL] [Abstract][Full Text] [Related]
57. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization. German CL; Hanson GR; Fleckenstein AE J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716 [TBL] [Abstract][Full Text] [Related]
58. Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities. Sweeney CG; Tremblay BP; Stockner T; Sitte HH; Melikian HE J Biol Chem; 2017 Jan; 292(4):1302-1309. PubMed ID: 27986813 [TBL] [Abstract][Full Text] [Related]